Kardjadj, M.; Priestly, I.P.; Chavez, R.; Derrick, D.; Huard, T.K.
Clinical Symptom Resolution Following PCR-Guided vs. Culture and Susceptibility-Guided Management of Complicated UTI: How Time-To-Antibiotic Start and Antibiotic Appropriateness Mediate the Benefit of Multiplex PCR—An Ad Hoc Analysis of NCT06996301. Diagnostics 2025, 15, 3107.
https://doi.org/10.3390/diagnostics15243107
AMA Style
Kardjadj M, Priestly IP, Chavez R, Derrick D, Huard TK.
Clinical Symptom Resolution Following PCR-Guided vs. Culture and Susceptibility-Guided Management of Complicated UTI: How Time-To-Antibiotic Start and Antibiotic Appropriateness Mediate the Benefit of Multiplex PCR—An Ad Hoc Analysis of NCT06996301. Diagnostics. 2025; 15(24):3107.
https://doi.org/10.3390/diagnostics15243107
Chicago/Turabian Style
Kardjadj, Moustafa, Itoe P. Priestly, Roel Chavez, DeAndre Derrick, and Thomas K. Huard.
2025. "Clinical Symptom Resolution Following PCR-Guided vs. Culture and Susceptibility-Guided Management of Complicated UTI: How Time-To-Antibiotic Start and Antibiotic Appropriateness Mediate the Benefit of Multiplex PCR—An Ad Hoc Analysis of NCT06996301" Diagnostics 15, no. 24: 3107.
https://doi.org/10.3390/diagnostics15243107
APA Style
Kardjadj, M., Priestly, I. P., Chavez, R., Derrick, D., & Huard, T. K.
(2025). Clinical Symptom Resolution Following PCR-Guided vs. Culture and Susceptibility-Guided Management of Complicated UTI: How Time-To-Antibiotic Start and Antibiotic Appropriateness Mediate the Benefit of Multiplex PCR—An Ad Hoc Analysis of NCT06996301. Diagnostics, 15(24), 3107.
https://doi.org/10.3390/diagnostics15243107
